Investigation of biological effects of IDH gene mutation in malignant glioma
Investigation of biological effects of IDH gene mutation in malignant glioma
批准号:
23791614
负责人:
TANAKA Masaki
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We investigated biological effects of glioma-related genetic alteration, IDH1 gene mutation, in human glioma cells. The IDH1R132H gene was introduced into highly transformed glioblastoma cells by transfection, and the cells overexpressing IDH1R132H were selected by G418 treatment. These cells did not exhibit significant changes in expression of tumor-, apoptosis-, or cell cycle-related genes, but were rather sensitive to CDDP treatment. Xenografts in athymic mice derived from these cells grew slower than parental cells. These results suggested that IDH1 mutation which is a hallmark of representative genetic alterations in lower grade glioma might bestow negative impact on aggressive behavior of higher grade gliomas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
今日の治療と看護 改訂第3版
今日治疗与护理修订版第三版
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[Ota I, Higashiyama S, Masui T, et al., 兵頭政光]
通讯作者:
兵頭政光
Bevacizumab monotherapy for recurrent malignant glioma ---Efficacy and prediction of response ---
贝伐珠单抗单药治疗复发性恶性胶质瘤——疗效和反应预测——
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[Nagane M, Tanaka M, 他4名]
通讯作者:
他4名
Combination treatment with the anti-EGFR monoclonal antibody, nimotuzumab, and temozolomide causes synergistic growth suppression of mutant EGFR expressing glioma xenografts
抗 EGFR 单克隆抗体、尼妥珠单抗和替莫唑胺的联合治疗可导致表达突变型 EGFR 的神经胶质瘤异种移植物的协同生长抑制
DOI:
--
发表时间:
2013
期刊:
Proceedings of 104th Annual Meeting of the American Association for Cancer Research
影响因子:
--
作者:
[Nagane M, Nitta Y, Shimizu S, Shishido-Hara Y, Shiokawa Y]
通讯作者:
Shiokawa Y
Multidrug immunochemotherapy (R-MPV-A) for newly diagnosed and recurrent primary central nervous system lymphomas.
用于新诊断和复发的原发性中枢神经系统淋巴瘤的多药免疫化疗(R-MPV-A)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[Motoo Nagane, Keiichi Kobayashi, Nobuyuki Takayama, Yoshiaki Shiokawa]
通讯作者:
Yoshiaki Shiokawa
Gliomaの遺伝子異常と治療成績
胶质瘤基因异常和治疗结果
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[亀田雅博, 上利崇, 若森孝彰, 新光阿以子, 菊池陽一郎, 佐々田晋, 佐々木達也, 大谷理浩, 新土居ロベルト, 伊達勲, 永根基雄]
通讯作者:
永根基雄
共 10 条
Development of wide scanning angle for millimeter wave beam by liquid crystal quasi-optical device with subwavelength structure
-
批准号:26390107
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2014
-
负责人:TANAKA Masaki
-
依托单位:
Involvement of RNA editing of 5HT2C receptor in emotion and stress: functional and morphological study
-
批准号:25290014
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2013
-
负责人:TANAKA Masaki
-
依托单位:
For the in vivo imaging of 5-HT2C receptor activity using Tango system
-
批准号:25640024
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:TANAKA Masaki
-
依托单位:
Development of a research technique to create animal model of brain lesions using therapeutic linear accelerator
-
批准号:24650206
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:TANAKA Masaki
-
依托单位:
The direct observation of lattice distortion using aberration corrected high-resolution transmission electron microscope
-
批准号:24686079
-
项目类别:Grant-in-Aid for Young Scientists (A)
-
资助金额:$15.23万
-
财政年份:2012
-
负责人:TANAKA Masaki
-
依托单位:
Temporal information processing in the basal ganglia and the cerebellum
-
批准号:23300139
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.9万
-
财政年份:2011
-
负责人:TANAKA Masaki
-
依托单位:
Ivan Pyr'ev and Rural Musical Comedies in the Soviet Union of the Stalin Era
-
批准号:23720070
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$1.33万
-
财政年份:2011
-
负责人:TANAKA Masaki
-
依托单位:
3D characterisation of microstructure around a crack tip by combining high-voltage electron microscopy and tomography.
-
批准号:22760544
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.66万
-
财政年份:2010
-
负责人:TANAKA Masaki
-
依托单位:
Functional morphology of neuropeptide RLN3-survey for the involvement in emotion and food intake-
-
批准号:21500329
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:TANAKA Masaki
-
依托单位:
Roles of the cortico-basal ganglia loop in rule-based behavioral choice
-
批准号:20300136
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2008
-
负责人:TANAKA Masaki
-
依托单位:
Physics of fracture to the brittle-ductile transition in poly-crystalline metals
-
批准号:19860059
-
项目类别:Grant-in-Aid for Young Scientists (Start-up)
-
资助金额:$1.99万
-
财政年份:2007
-
负责人:TANAKA Masaki
-
依托单位:
Functional and morphological analysis of a novel peptide relaxin 3 in the central nervous system
-
批准号:18500268
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.63万
-
财政年份:2006
-
负责人:TANAKA Masaki
-
依托单位:
Analysis of a novel peptide INSL7 in the central nervous system
-
批准号:16500224
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:TANAKA Masaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
NLRP3抑制Mito PYCR1促进 IDH1/2野生型胶质瘤焦亡诱发脑水肿机制研究
-
批准号:2026JJ82626
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐慧
-
依托单位:
GADD45B诱导IDH1降解促进心肌细胞铁死亡介导脓毒症心肌病发生发展的作用及机制研究
-
批准号:2026JJ60291
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周阳
-
依托单位:
葡萄糖剥夺通过抑制IDH1和H3K9乳酸化修饰诱导仑伐替尼耐药肝细胞癌双硫死亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:唐陈伟
-
依托单位:
基于IDH1琥珀酰化修饰调控
CXCL12/CXCR4轴探讨驻车丸防治肠炎相
关结直肠癌的作用及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:张晓君
-
依托单位:
靶向IDH1突变的分子探针构建及其在脑胶质瘤精准诊断的PET/MRI
成像研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈晓
-
依托单位:
Fonsecaea monophora通过抑制IDH1激活Irg1-衣康酸通路减弱巨噬细胞的免疫防御功能
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:张军民
-
依托单位:
Nr4a1的甲基化修饰调控IDH1在慢性应激所致颗粒细胞衰老中的作用及机制研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2024
-
负责人:孙俊艳
-
依托单位:
基于“IDH1乳酸化-NADPH/NOX2代谢轴探究健脾益肾法通过调控巨噬细胞极化激活生殖干细胞以延缓卵巢衰老的作用机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:--
-
依托单位:
Triptonide 通过 CHIP 介导的蛋白酶体途径清
除野生型IDH1 急性髓系白血病细胞的机制
研究
-
批准号:TGY24H080029
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨琳琳
-
依托单位:
Aβ-E2/IDH1轴调控女性AD病理中小胶质细胞NLRP3炎症小体激活
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:卢健
-
依托单位: